Advertisement
Ear/Nose/Throat
Subscribe to Ear/Nose/Throat
View Sample

FREE Email Newsletter

Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator

August 17, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Former Congressman and PhRMA CEO Billy Tauzin has joined the board of the pharmaceutical benefits management company CaptureRx . He will also serve as the company's Chief Industry Relations Officer. Tauzin will work on behalf of...

The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face

August 17, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 17, 2011 /- The 14th annual Victory Over Diabetes event, hosted by the American Diabetes Association (the Association), will take place in Atlanta on August 20, featuring educational workshops, free health screenings and resources designed to encourage African Americans to...

FDA Proposes Guidelines That Clarify Benefit-Risk Determinations for Medical Devices

August 15, 2011 8:47 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Aug. 15, 2011 /PRNewswire-USNewswire/ -- For the first time, the U.S. Food and Drug Administration has provided draft guidance clarifying how benefit-risk determinations are made during premarket review of certain medical devices. (Logo:...

Advertisement

An Easier Test for TB

August 9, 2011 9:44 pm | by Massachusetts Institute of Technology | News | Comments

A study suggests that an electronic nose could sniff out tuberculosis in a urine sample.

PhotoMedex Covers XTRAC Laser Treatment Co-Pay for Children with Psoriasis

August 4, 2011 5:46 am | by Bio-Medicine.Org | News | Comments

MONTGOMERYVILLE, Pa., Aug. 4, 2011 /- PhotoMedex , Inc. (NASDAQ: PHMD ), an innovator of medical devices, today launches a co-pay reimbursement offer*  to assist the families of children who suffer from psoriasis.  In honor of the National Psoriasis Awareness Month in August...

BioMarCare Technologies Ltd. Receives a $900k Grant for a Joint Project with Ariadne Inc.

August 2, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 2, 2011 /- Hadasit Bio-Holdings, Ltd. - (OTCBB: HADSY), a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, and its subsidiary, BioMarCare...

Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

ST. PAUL, Minn., Aug. 2, 2011 /- Apnex Medical, Inc., received investigational device exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin a clinical study to evaluate the safety and effectiveness of its Hypoglossal Nerve Stimulation (HGNS®) System to...

Siemens Partners with American Cancer Society to Make Strides Against Breast Cancer

August 2, 2011 6:45 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Aug. 2, 2011 /- Today, Siemens announced that it is partnering with the American Cancer Society (ACS) in support of its premier national event to fight breast cancer – Making Strides Against Breast Cancer. The company, a pioneer in the fields of industry, energy, and...

Advertisement

A Quick, Cheap Diagnostic Test for HIV and Other Infections

August 1, 2011 11:41 am | by Massachusetts Institute of Technology | News | Comments

A simple microfluidics chip could improve health care in poor countries by making rapid diagnostic testing a reality.

Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for Inadequate Leukemia and Cancer Warning

July 29, 2011 9:46 am | by Bio-Medicine.Org | News | Comments

DALLAS, July 29, 2011 /- Humira defect lawyers filed a lawsuit against Abbott Laboratories in Texas state court claiming Abbott's blockbuster drug, Humira, caused a life-threatening disease, leukemia. "Eleven year-old Bo Anderson was prescribed Humira for a skin condition, psoriasis....

Post Robotic Prostate Surgery Continence and Pelvic Floor Muscles

July 27, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

NEW YORK, July 27, 2011 /- For men facing radical prostatectomy procedures, elimination of their prostate cancer is not their only concern. In fact, a large number of these men list damage to their sexual potency and urinary continence among their biggest fears. More than 240,000 men will...

Targeting PTEN May Prevent Skin Cancer(2)

July 26, 2011 9:38 am | by AACR | News | Comments

Tweet   • The tumor suppressor PTEN played key role in radiation damage repair. • Skin cancer is the most common type of cancer in the United States. PHILADELPHIA - Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from...

Latest Information on Obese Patients with Type 2 Diabetes and LAP-BAND System

July 25, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, July 25, 2011 /- Bariatric surgery is recommended by IDF, the International Diabetes Foundation, for obese patients with type 2 diabetes. According to a new IDF position paper, bariatric surgeries for these obese patients can reduce health care costs in the long run....

Advertisement

Thermo Fisher licenses biomarker assays to Alere

July 21, 2011 9:46 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Life sciences equipment supplier Thermo Fisher Scientific Inc. today announced that it has signed a license agreement with Alere Inc. to add its BRAHMS biomarker assays to Alere's point-of-care Triage platform.

Isis Initiates Phase 1 Study of ISIS-PTP1BRx to Treat Type 2 Diabetes

July 21, 2011 3:41 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., July 21, 2011 /- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ) announced today that it has initiated a Phase 1 clinical study for ISIS-PTP1BRx, an antisense drug for the treatment of type 2 diabetes targeting protein tyrosine phosphatase-1B, PTP-1B.  ISIS-PTP1BRx is...

Solos Endoscopy's MammoView® System Proves Crucial to Early Breast Cancer Detection

July 20, 2011 6:43 am | by Bio-Medicine.Org | News | Comments

BOSTON, July 20, 2011 /- Solos Endoscopy, Inc.'s (OTCPK: SNDY) MammoView® instrument line, designed exclusively for breast endoscopy, has become crucial to early breast cancer screening as a method to significantly reduce breast cancer death rates. The Solos MammoView® Breast...

FluMist® (Influenza Vaccine Live, Intranasal) Begins Shipping for 2011-2012 Influenza Season

July 18, 2011 10:51 am | by Bio-Medicine.Org | News | Comments

GAITHERSBURG, Md., July 18, 2011 /- MedImmune announced today that it has begun shipping FluMist® (Influenza Vaccine Live, Intranasal) to influenza vaccine distributors who service health care providers throughout the United States.   MedImmune expects to provide approximately...

Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited

July 12, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

ONTARIO, Canada, July 12, 2011 /- Panacea Global, Inc., ("the Company") (OTCQB: PANG), a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced that it has signed a multi-year exclusive sales agreement with...

IDEV Technologies Launches Lower Profile SUPERA VERITAS® Stent Delivery System

July 12, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

WEBSTER, Texas, July 12, 2011 /- IDEV Technologies, Incorporated (IDEV), today announced the first procedures in Europe utilizing the new 6 French (6Fr) SUPERA VERITAS® Peripheral Vascular System.  The new lower profile delivery system offers physicians more treatment options,...

MedImage Cases™: A New Medical e-Textbook from Projects In Knowledge®

July 12, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., July 12, 2011 /- Projects In Knowledge ( www.projectsinknowledge.com ), the leading developer of cutting-edge digital and mobile information tools for busy clinicians, has just launched its newest free electronic medical textbook series: MedImage Cases, offered online...

High Precision Pressure Sensors in CPAP Respiratory Therapy Equipment

July 11, 2011 12:41 pm | by Dr. Adriano Pittarelli | Articles | Comments

Continuous Positive Airway Pressure (CPAP) machines are used to treat sleep apnea, a disorder that restricts breathing, and potentially causes stress to both the heart and circulatory system. Sensortechnics’ HDI and HCE series pressure sensors monitor the instantaneous pressure at the output of the machine and inside the breathing mask, increasing accuracy and sensitivity for individual CPAP users. 

Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology

July 7, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

PAMPLONA, Spain, July 7, 2011 /-   Results of the multi-centre European Network on Radioembolization with Yttrium-90 Resin Microspheres (ENRY) analysis of the long-term outcomes related to survival and safety of radioembolization using SIR-Spheres in patients with inoperable primary...

Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare

June 30, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 30, 2011 /PRNewswire-USNewswire/ -- The Council on Competitiveness, in partnership with the Defense Advanced Research Projects Agency (DARPA), is releasing a case study today highlighting the potential for high performance computing (HPC) to spur innovative solutions for...

A Wristwatch that Monitors Blood Pressure

June 29, 2011 8:32 pm | by Massachusetts Institute of Technology | News | Comments

Researchers hope a device that tracks vital signs around the clock will help patients better control their blood pressure.

The Lancet Publishes Data from Protege, MacroGenics' Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients

June 28, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

ROCKVILLE, Md., June 28, 2011 /- MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, announced the publication in The Lancet of results from Protege, a Phase 3 clinical study of...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading